Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Sumathi, Nambiar"'
Autor:
Amy Corneli, Chris Wheeler, John Bradley, Breck Gamel, Sumathi Nambiar, Gary J. Noel, Li Lin, Jamie N. Roberts, Daniel K. Benjamin, Jr.
Publikováno v:
Contemporary Clinical Trials Communications, Vol 9, Iss C, Pp 115-120 (2018)
An urgent need exists to develop new antibacterial drugs for children. We conducted research with investigators of pediatric antibacterial drug trials to identify facilitators and barriers in the conduct of these trials. Seventy-three investigators c
Externí odkaz:
https://doaj.org/article/4eccc4ab334a4d699cd9ae805a06635e
Autor:
Rachel G. Greenberg, Amy Corneli, John Bradley, John Farley, Hasan S. Jafri, Li Lin, Sumathi Nambiar, Gary J. Noel, Chris Wheeler, Rosemary Tiernan, P. Brian Smith, Jamie Roberts, Daniel K. Benjamin, Jr.
Publikováno v:
Contemporary Clinical Trials Communications, Vol 9, Iss C, Pp 7-12 (2018)
Despite legislation to stimulate pediatric drug development through clinical trials, enrolling children in trials continues to be challenging. Non-investigator (those who have never served as a clinical trial investigator) providers are essential to
Externí odkaz:
https://doaj.org/article/85599ffdeb79468c83dab72b8ba406ac
Autor:
Rachel G. Greenberg, Breck Gamel, Diane Bloom, John Bradley, Hasan S. Jafri, Denise Hinton, Sumathi Nambiar, Chris Wheeler, Rosemary Tiernan, P. Brian Smith, Jamie Roberts, Daniel K. Benjamin, Jr.
Publikováno v:
Contemporary Clinical Trials Communications, Vol 9, Iss C, Pp 33-39 (2018)
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies to improve recruitment of children into trials are needed. This study used in-depth qualitative interviews with parents who were approached to enroll
Externí odkaz:
https://doaj.org/article/750de16bd1904e0d9bd108dd55915219
Autor:
Xiaohui, Wei, Shabnam, Naseer, Edward A, Weinstein, Dmitri, Iarikov, Sumathi, Nambiar, Kellie S, Reynolds, Seong H, Jang
Publikováno v:
Clinical Pharmacology & Therapeutics. 112:1004-1007
In this report, we describe our scientific approach for including effluent flow rate (Q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b44f8444bfb9f5001a36a16617773b8
https://doi.org/10.1002/cpt.2703
https://doi.org/10.1002/cpt.2703
Autor:
Yuliya Yasinskaya, Shukal Bala, Ursula Waack, Cheryl Dixon, Karen Higgins, Jason N Moore, Caroline J Jjingo, Elizabeth O'Shaughnessy, Philip Colangelo, Radu Botgros, Sumathi Nambiar, David Angulo, Aaron Dane, Tom Chiller, Michael R Hodges, Taylor Sandison, William Hope, Thomas J Walsh, Peter Pappas, Aspasia Katragkou, Laura Kovanda, John H Rex, Kieren A Marr, Luis Ostrosky-Zeichner, Shohko Sekine, Monika Deshpande, Sunita J Shukla, John Farley
Publikováno v:
Clinical Infectious Diseases.
Pressing challenges in the treatment of invasive fungal infections (IFIs) include emerging and rare pathogens, resistant/refractory infections, and antifungal armamentarium limited by toxicity, drug-drug interactions, and lack of oral formulations. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13aeec0d6978925d410973556a32de81
https://doi.org/10.1093/cid/ciad195
https://doi.org/10.1093/cid/ciad195
Autor:
Tori Kinamon, Ramya Gopinath, Ursula Waack, Mark Needles, Daniel Rubin, Deborah Collyar, Sarah B Doernberg, Scott R Evans, Toshimitsu Hamasaki, Thomas L Holland, Jessica Howard-Anderson, Henry Chambers, Vance G Fowler, Sumathi Nambiar, Peter Kim, Helen W Boucher
Publikováno v:
Open Forum Infectious Diseases. 9
Background Desirability of outcome ranking (DOOR) uses an ordinal ranking system to evaluate global outcomes in clinical trial participants by incorporating safety and efficacy assessments into a single endpoint. In this study, we developed and appli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0d3ddea3f0c0f7b4962305cd76d4723
https://doi.org/10.1093/ofid/ofac492.301
https://doi.org/10.1093/ofid/ofac492.301
Autor:
Kalavati Suvarna, Daniel B. Rubin, Seong H. Jang, Sumathi Nambiar, John Farley, Edward A. Weinstein, Karen Higgins, Dmitri Iarikov, Xiaohui Wei, Shabnam Naseer, Avery Goodwin
Publikováno v:
Clinical Infectious Diseases. 72:e1103-e1111
In November 2019, the Food and Drug Administration (FDA) approved cefiderocol for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis caused by susceptible gram-negative bacteria in adults with limited to no alternat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd9cce7b14affc891f3241c37d20ddd2
https://doi.org/10.1093/cid/ciaa1799
https://doi.org/10.1093/cid/ciaa1799
Publikováno v:
Clinical Infectious Diseases. 73:e602-e608
Background New drug development for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) is critical. Challenges remain in the conduct of HABP/VABP trials, especially in the contexts of enrollment, endpoin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4a9ee616b1e1f63e4e1a08eb173e505
https://doi.org/10.1093/cid/ciaa1712
https://doi.org/10.1093/cid/ciaa1712
Autor:
Stephen J Page, John H. Rex, Lisa F. Shubitz, Edward P. Garvey, Karen Higgins, Neil M. Ampel, Yuliya Yasinskaya, David Angulo, Antonino Catanzaro, Kellie S. Reynolds, Janis E. Blair, Cheryl Dixon, Sunita J Shukla, David J Larwood, David A. Stevens, John N. Galgiani, Sumathi Nambiar, Rob Purdie, Royce H. Johnson, John J Farley, Jason N. Moore, Elizabeth O'Shaughnessy, Gareth Lewis
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 74(11)
Coccidioidomycosis is a fungal disease endemic to the southwestern United States, Mexico, and Central and South America. Prevalence rates are increasing steadily, and new endemic areas of Coccidioides are emerging. Standard treatment is often adminis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6588b1d98e8a5f1807a413c0d50d9cf
https://pubmed.ncbi.nlm.nih.gov/34651656
https://pubmed.ncbi.nlm.nih.gov/34651656
Publikováno v:
ACS Infectious Diseases. 6:1308-1310
The growing concern of antimicrobial resistance coupled with the dearth of new antibacterial agents in development is a major public health threat. Multiple stakeholder efforts are underway to address the various challenges facing this field; while s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24b56001304a192db3da7b9f1a439ca
https://doi.org/10.1021/acsinfecdis.0c00270
https://doi.org/10.1021/acsinfecdis.0c00270